Pharmerica Stock Analysis, Valuation (NYSE:PMC)

Add to My Stocks
$29.1 $0.05 (0.17%) PMC stock closing price Aug 22, 2017 (Closing)
Watch Robo Advisor Video of PMC Stock Analysis
Pharmerica
Updated on : Aug 22, 2017
previous close
PMC 29.1 (0%)
S&P 500 2452.5 (0%)
Closing Price On: Aug 22, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Outpatient-Home care
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2017-Q2
$million
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
2%
Sector Average:
-2.2%
5 Quarter Net Profit
Net Margins
2017-Q2
%
LTM Margin
Compared to the industry
Debt/Equity Ratio
Debt:
432.9M
Debt/Equity Ratio:
 0.78
Compared to the industry
Cash Flow
Operating cash flow:
$42.5M
Net Income:
$4.7M
PROS      CONS
ROIC
ROE
FCF Margin
PE Valuation
PS Valuation
High Debt Burden
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
PMC PS :
0.4
Industry PS :
5
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
2.9%
Return on Equity:
4.3%
Free Cash Flow Margin:
5.8%
Double Tap To Exit Full Screen
0:00
/

Pharmerica Analysis Video

42 5 2

View Pharmerica stock analysis video. This is our PMC analyst opinion covering the buy and sell arguments for PMC stock.

PharMerica Corporation Stock Rating (3.6/5)

Our Pharmerica stock opinion is based on fundamentals of the company. This Pharmerica stock analysis is based on latest 2017 Q2 earnings. The stock price analysis takes into account the company's valuation metrics.

Should you buy PMC stock?

  • PMC stock is trading at an earnings multiple of 15.2 which is better than the industry average of 22.7.
  • When compared with the Medical-Outpatient-Home care industry average PS ratio of 5, the price-to-sales ratio of 0.4 for PMC stock is attractive.
  • Pharmerica's return on invested capital of 2.9% is good.
  • The LTM ROE of 4.3% for Pharmerica is attractive.
  • The company has a good Free Cash Flow (FCF) margin of 5.8%.

Should you sell PMC stock?

  • With a debt/equity ratio of  0.78, Pharmerica is highly leveraged in comparison to Medical peers.

Comments on this video and Pharmerica stock